Avastin Passes Tox Test In Colon Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug and control arms in C-08 study of Genentech drug turn out the same.
You may also be interested in...
Avastin Breast Cancer Approval In Spotlight With AVADO
CHICAGO - First placebo-controlled, double-blinded evidence for bevacizumab in first-line metastatic breast cancer presented at ASCO.
Genentech Expects Avastin Colon Cancer Data Ahead Of Schedule In 2009
Revised timeline for the C-08 trial does not change Genentech’s assessment of probability of success.
“Creative” FDA Clears Avastin For First-Line Breast Cancer
Accelerated approval wants more clinical proof.